Biotechnology And Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report By Services (Consulting, Auditing and Assessment, Regulatory Affairs), By End-use (Pharma, Biotech), By Region, And Segment Forecasts, 2024 - 2030

Research Methodology

A three-pronged approach was followed for deducing the biotechnology and pharmaceutical services outsourcing market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for biotechnology and pharmaceutical services outsourcing market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of biotechnology and pharmaceutical services outsourcing market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Biotechnology And Pharmaceutical Services Outsourcing Market Categorization:

The biotechnology and pharmaceutical services outsourcing market was categorized into three segments, namely service (Consulting, Auditing & Assessment, Regulatory Affairs, Product Maintenance, Product Design & Development, Product Testing & Validation, Training & Education), end-use (Pharma, Biotech), regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The biotechnology and pharmaceutical services outsourcing market was segmented into service, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The biotechnology and pharmaceutical services outsourcing market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Smart home market companies & financials:

The biotechnology and pharmaceutical services outsourcing market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• THE QUANTIC GROUP - The Quantic Group provides industry and government biotechnology and pharmaceutical consulting services. It operates through various segments, such as regulatory affairs, research, development, manufacturing, and quality operations. Quantic has supportive clients from all over the globe that mainly operate in regulatory affairs. It also provides services in other segments such as marketing & manufacturing strategies, clinical trial practices, research & development, product, manufacturing & quality systems methodologies, and others.

• IQVIA HOLDINGS, INC. - IQVIA Holdings, Inc. is one of the leading companies that provides contract research services, technology solutions, and advanced analytics to the global life sciences industry. The company operates through three main business areas- R&D solutions, commercialization solutions, and technology solutions. It serves biotechnology, consumer health, pharmaceuticals, and device & diagnostics companies in North America, Europe, Asia Pacific, and Africa. IQVIA also serves pharmacies, pharmaceutical distributors, payers, and government & regulatory agencies.

• PAREXEL INTERNATIONAL CORPORATION - Parexel International Corporation is a healthcare company that provides biopharmaceutical and pharmaceutical services worldwide. It provides biopharmaceutical services to various clients across the globe and also offers new treatment options for various rare disorders. It serves biotechnology, consumer health companies, pharmaceutical, and device & diagnostic companies in North America, Europe, Asia Pacific, and Africa. It operates through different segments, such as clinical trials, regulatory, consulting, and market access. It provides services to more than 100 countries. They also outsource their services to different pharmacies, pharmaceutical distributors, payers, & regulatory agencies.

• LACHMAN CONSULTANT SERVICES - Lachman Consultant Services provides technical and regulatory affairs services to clients worldwide. It also consults other organizations to solve their problems and develop effective strategies for approval of new drugs and devices. It also provides consulting services to global clients such as pharmaceutical, biotechnology, medical devices, and dietary supplement companies. It provides services in North America, Europe, and Asia Pacific regions.

• GMP PHARMACEUTICALS - GMP Pharmaceuticals is one of the leading manufacturers of medicines, natural health products, and infant formulas. It serves health food companies across the globe. For example, it has around 20 years of experience providing worldwide nutritional and health food services. GMP Pharmaceuticals manufactures various pharmaceutical products such as coated & uncoated tablets, liquids, capsules, creams, ointments, and powders. It is the only contract manufacturer in Australia and New Zealand.

• CONCEPT HEIDELBERG GMBH - Concept Heidelberg GmbH is one of the leading organizations in Europe that provides training and information services in pharmaceutical quality assurance and drug quality. It organizes more than 350 seminars and conferences at least in 10 European countries every year. It provides GMP/GDP services to various pharmaceutical & biopharmaceutical industries, such as in-house training, e-learning, and consulting services.

• COVANCE, INC. - Covance, Inc. is a contract research organization that provides clinical and commercialization services to the biopharmaceutical and pharmaceutical industries. LabCorp owns the company. It provides its services over 60 countries. Covance is the world's most wide-ranging drug development company that delivers solutions to pharmaceutical industries. It also offers laboratory testing services to chemical industries and is a market leader in discovery, toxicology, & central laboratory services. It is one of the top companies that provides management services in phase III clinical trials to pharmaceutical industries.

• CHARLES RIVER - Charles River Laboratory provides clinical laboratory and preclinical services for the pharmaceutical and biotechnology industries. Charles operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support. Its DSA segment offerings include bioanalysis, drug metabolism, toxicology, and pharmacokinetics services. It caters its products and services to biotechnology and pharmaceutical companies, medical device companies, hospitals, clinics, and academic institutions. The company provides its products in about 20 countries and has a presence in Canada, Finland, Belgium, France, Hungary, Germany, Italy, China, Italy, Japan, Spain, the Netherlands, and the UK.

• PRA HEALTH SCIENCES - PRA Health Sciences provides outsourced clinical development and data solution services to biopharmaceutical & pharmaceutical industries globally. It operates in different therapeutic areas, such as immunology, inflammation, and infectious diseases. The company provides services to various geographic regions such as North America, Europe, Asia, Latin America, South Africa, Australia, and the Middle East.

• ICON PLC - ICON provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries globally. The company specializes in the strategic development, management, and analysis of programs that support Clinical Development from compound selection to Phase I-IV clinical studies. The company offers a complete range of services, including consulting, development, and commercialization, from a global network of offices in 37 countries.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

Biotechnology And Pharmaceutical Services Outsourcing Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Biotechnology And Pharmaceutical Services Outsourcing Market Report Assumptions:

• The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.